166 related articles for article (PubMed ID: 20608286)
1. Exempt chemical mixtures containing gamma-butyrolactone. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2010 Jun; 75(124):37301-7. PubMed ID: 20608286
[TBL] [Abstract][Full Text] [Related]
2. Placement of gamma-butyrolactone in List I of the Controlled Substances Act (21 U.S.C. 802(34)). Drug Enforcement Administration, Justice. Final rule.
Fed Regist; 2000 Apr; 65(79):21645-7. PubMed ID: 11010670
[TBL] [Abstract][Full Text] [Related]
3. Exemption of chemical mixtures containing the List I chemicals ephedrine, N-methylephedrine, N-methylpseudoephedrine, norpseudoephedrine, phenylpropanolamine, and pseudoephedrine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 May; 68(84):23195-206. PubMed ID: 12725239
[TBL] [Abstract][Full Text] [Related]
4. Exemption of chemical mixtures. Final rule.
Drug Enforcement Administration (DEA), U.S. Department of Justice
Fed Regist; 2007 Mar; 72(47):10925-8. PubMed ID: 17450656
[TBL] [Abstract][Full Text] [Related]
5. Elimination of exemptions for chemical mixtures containing the list I chemicals ephedrine and/or pseudoephedrine. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2008 Jul; 73(133):39611-4. PubMed ID: 18850676
[TBL] [Abstract][Full Text] [Related]
6. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Interim rule with request for comments.
Drug Enforcement Administration (DEA), U.S. Department of Justice
Fed Regist; 2007 Apr; 72(77):20039-47. PubMed ID: 17520757
[TBL] [Abstract][Full Text] [Related]
7. Changes in the regulation of iodine crystals and chemical mixtures containing over 2.2 percent iodine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2007 Jul; 72(126):35920-31. PubMed ID: 17910137
[TBL] [Abstract][Full Text] [Related]
8. Definition of "positional isomer" as it pertains to the control of schedule I controlled substances. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2007 Dec; 72(231):67850-2. PubMed ID: 18064769
[TBL] [Abstract][Full Text] [Related]
9. Control of red phosphorus, white phosphorus and hypophosphorous acid (and its salts) as list I chemicals; exclusions and waivers. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 Jun; 68(121):37411-4. PubMed ID: 12836650
[TBL] [Abstract][Full Text] [Related]
10. Recordkeeping and reporting requirements for drug products containing gamma-hydroxybutyric acid (GHB). Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2005 Jan; 70(2):291-4. PubMed ID: 15630794
[TBL] [Abstract][Full Text] [Related]
11. Designation of Alpha-Phenylacetoacetonitrile (APAAN), a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine, as a List I Chemical. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Jul; 82(134):32457-61. PubMed ID: 28715162
[TBL] [Abstract][Full Text] [Related]
12. Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2004 Sep; 69(188):58950-3. PubMed ID: 15455477
[TBL] [Abstract][Full Text] [Related]
13. Listed chemicals; establishment of non-regulated transactions in anhydrous hydrogen chloride. Final rule confirmation.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2001 Aug; 66(159):42944-6. PubMed ID: 11757558
[TBL] [Abstract][Full Text] [Related]
14. Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2002 Oct; 67(194):62354-70. PubMed ID: 12369590
[TBL] [Abstract][Full Text] [Related]
15. Schedules of controlled substances; placement of 2,5-dimethoxy-4-(n)-propylthiophenethylamine and N-benzylpiperazine into Schedule I of the Controlled Substances Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2004 Mar; 69(53):12794-7. PubMed ID: 15029891
[TBL] [Abstract][Full Text] [Related]
16. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2008 Jul; 73(144):43355-7. PubMed ID: 18949877
[TBL] [Abstract][Full Text] [Related]
17. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486
[TBL] [Abstract][Full Text] [Related]
18. Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2010 Dec; 75(243):79296-300. PubMed ID: 21171485
[TBL] [Abstract][Full Text] [Related]
19. Implementation of the Methamphetamine Production Prevention Act of 2008. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2011 Dec; 76(231):74696-9. PubMed ID: 22145189
[TBL] [Abstract][Full Text] [Related]
20. Schedules of controlled substances: placement of pregabalin into schedule V. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2005 Jul; 70(144):43633-5. PubMed ID: 16050051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
